158 related articles for article (PubMed ID: 21894796)
1. Low safety index of domperidone: mechanism for increased odds ratio for sudden cardiac death.
Hondeghem LM
Acta Cardiol; 2011 Aug; 66(4):421-5. PubMed ID: 21894796
[TBL] [Abstract][Full Text] [Related]
2. Domperidone: limited benefits with significant risk for sudden cardiac death.
Hondeghem LM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
[TBL] [Abstract][Full Text] [Related]
3. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
[TBL] [Abstract][Full Text] [Related]
4. Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts.
Hondeghem LM
Prog Biophys Mol Biol; 2016 May; 121(1):3-10. PubMed ID: 26980523
[TBL] [Abstract][Full Text] [Related]
5. Domperidone and long QT syndrome.
Rossi M; Giorgi G
Curr Drug Saf; 2010 Jul; 5(3):257-62. PubMed ID: 20394569
[TBL] [Abstract][Full Text] [Related]
6. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
[No Abstract] [Full Text] [Related]
7. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
Buffery PJ; Strother RM
N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
[TBL] [Abstract][Full Text] [Related]
8. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
[TBL] [Abstract][Full Text] [Related]
9. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
10. Domperidone and sudden cardiac death: How much longer should we wait?
Michaud V; Turgeon J
J Cardiovasc Pharmacol; 2013 Mar; 61(3):215-7. PubMed ID: 23328387
[No Abstract] [Full Text] [Related]
11. Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis.
Mehrabadi A; Reynier P; Platt RW; Filion KB
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1316-1324. PubMed ID: 30106193
[TBL] [Abstract][Full Text] [Related]
12. Domperidone: QT prolongation in infants.
Prescrire Int; 2011 Jan; 20(112):14. PubMed ID: 21462787
[No Abstract] [Full Text] [Related]
13. [Domperidone and the risk of sudden cardiac death].
van Roeden SE; Belle-van Meerkerk G; van Tuyl SA; van de Ree MA; Muller AF
Ned Tijdschr Geneeskd; 2013; 157(45):A6770. PubMed ID: 24191928
[TBL] [Abstract][Full Text] [Related]
14. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
Rochoy M; Auffret M; Béné J; Gautier S;
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
[TBL] [Abstract][Full Text] [Related]
15. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
Johannes CB; Varas-Lorenzo C; McQuay LJ; Midkiff KD; Fife D
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):881-8. PubMed ID: 20652862
[TBL] [Abstract][Full Text] [Related]
16. QTc prolongation as a surrogate for drug-induced arrhythmias: fact or fallacy?
Hondeghem LM
Acta Cardiol; 2011 Dec; 66(6):685-9. PubMed ID: 22299377
[TBL] [Abstract][Full Text] [Related]
17. Domperidone, Parkinson disease and sudden cardiac death: Mice and men show the way.
Scorza FA; Scorza CA; Ferraz HB
Clinics (Sao Paulo); 2016 Feb; 71(2):59-61. PubMed ID: 26934232
[No Abstract] [Full Text] [Related]
18. Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France.
Hill C; Nicot P; Piette C; Le Gleut K; Durand G; Toussaint B
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):543-7. PubMed ID: 25832309
[TBL] [Abstract][Full Text] [Related]
19. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
Hondeghem LM; Carlsson L; Duker G
Circulation; 2001 Apr; 103(15):2004-13. PubMed ID: 11306531
[TBL] [Abstract][Full Text] [Related]
20. Use of domperidone to increase breast milk supply: are women really dying to breastfeed?
Grzeskowiak L
J Hum Lact; 2014 Nov; 30(4):498-9. PubMed ID: 25320114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
